Botulinum toxin as an off-label treatment of other primary and secondary headaches

被引：0

作者：

Nunes Vicente, B. ^{[1
]}

Dourado Sotero, F. ^{[1
,2
]}

Pavao Martins, I. ^{[1
,2
,3
]}

机构：

[1] Ctr Hosp Univ Lisboa Norte, Headache Ctr, Lisbon, Portugal

[2] Univ Lisbon, Fac Med, Lisbon, Portugal

[3] Univ Lisbon, Fac Med, Ctr Estudos Egas Moniz, Lisbon, Portugal

来源：

JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P064

引用

页数：2

共 50 条

[31] Botulinum toxinDiplopia and off label label doses of botulinum toxin for left leg spasticity: case report
Reactions Weekly, 2018, 1722 (1) : 80 - 80
[32] Role of botulinum toxin type A in the prophylactic treatment of migraine headaches
Chilson, CN
Brown, SJ
ANNALS OF PHARMACOTHERAPY, 2005, 39 (12) : 2081 - 2085
[33] Eisai warns of toxin spread with off-label use of Neurobloc
Reactions Weekly, 2013, 1442 (1) : 2 - 2
[34] DexamethasoneAspergillosis secondary to off-label use: case report
Reactions Weekly, 2022, 1935 (1) : 177 - 177
[35] Off-label use of bottilinurn toxin: Aspects of efficacy and safety
Stolze, H.
Pohle, S.
AKTUELLE NEUROLOGIE, 2006, 33 (05) : 275 - 283
[36] Open-label study of Myobloc (botulinum toxin type B) in the treatment of patients with transformed migraine headaches
Opida, CL
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R33 - R33
[37] Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders
Argyriou, Andreas A.
Mitsikostas, Dimos-Dimitrios
Mantovani, Elisa
Vikelis, Michail
Tamburin, Stefano
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (08) : 923 - 944
[38] SpironolactoneHyperkalaemia secondary to off-label use: case report
Reactions Weekly, 2021, 1836 (1) : 710 - 710
[39] OsimertinibPneumonitis secondary to off-label use: case report
Reactions Weekly, 2020, 1814 (1) : 283 - 283
[40] Off-label prescribing in the treatment of dermatologic disease
Sugarman, JH
Fleischer, AB
Feldman, SR
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (02) : 217 - 223

← 1 2 3 4 5 →